These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4552131)

  • 1. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 4. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    Simpson GM; Beckles D; Isalski Z; Lee JH
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 6. The rabbit syndrome. A peculiar extrapyramidal reaction.
    Villeneuve A
    Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 8. Sleeplessness in acute and chronic schizophrenia--response to haloperidol and anti-parkinsonism agents.
    Singh MM; Smith JM
    Psychopharmacologia; 1973 Feb; 29(1):21-32. PubMed ID: 4571938
    [No Abstract]   [Full Text] [Related]  

  • 9. Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
    Jellinek T
    Dis Nerv Syst; 1977 May; 38(5):353-5. PubMed ID: 852367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary tests with injectable biperiden in the treatment of neurodysleptic crises induced by neuroleptic drugs].
    Madalena JC
    Hospital (Rio J); 1969 Aug; 76(2):497-500. PubMed ID: 5307639
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of indication for use of antiparkinson medication. A follow-up study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 15. Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics.
    Schifano F; di Costanzo E
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):184-6. PubMed ID: 2071270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of psychotropic drug use for schizophrenia.
    Laska E; Varga E; Wanderling J; Simpson G; Logemann GW; Shah BK
    Dis Nerv Syst; 1973; 34(6):294-305. PubMed ID: 4782286
    [No Abstract]   [Full Text] [Related]  

  • 18. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 19. High dosage chlorpromazine alone and in combination with an antiparkinsonian agent (procyclidine) in the treatment of hospitalized depressions.
    Raskin A
    J Nerv Ment Dis; 1968 Aug; 147(2):184-95. PubMed ID: 4877904
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.